News

MyChesCo on MSN1d
Arbutus Biopharma Showcases Promising Results for Hepatitis B Therapies at EASL Congress 2025
Arbutus Biopharma Corporation (Nasdaq: ABUS) recently presented compelling data on its investigational hepatitis B therapies, ...
Medical Xpress19d
Childhood hepatitis B treatment linked to higher odds of long-term virus control
Functional cure, defined as durable hepatitis B surface antigen (HBsAg) and hepatitis B virus (HBV) DNA titers below the lower limit of detection (LLOD), is associated with better clinical ...
C&EN20d
Quantitative Analysis of Wettability and Its Transition Mechanism in Carbonate Rocks Based on Surface Energy Characterization
Find more information about Crossref citation counts. The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon ...
Business Wire26d
Precision BioSciences Receives U.S. FDA Fast Track Designation for PBGENE-HBV, a First-In-Class Gene Editing Therapy Designed to Eliminate the Root Cause of Chronic Hepatitis B
the primary source of hepatitis B surface antigen (HBsAg) in late-stage disease. Current treatments for patients with HBV infection include agents that result in long-term viral suppression as ...
Frontiers1mon
Discussion on the duration of response following HBsAg clearance in patients with chronic hepatitis B treated with PegIFNα-2b
Patient demographic information (including age and sex) was recorded along with baseline peripheral blood liver function tests, complete blood counts, hepatitis B serological markers including HBV DNA ...
Frontiers1y
A hepatitis B virus-derived peptide combined with HBsAg exerts an anti-HBV effect in an HBV transgenic mouse model as a therapeutic vaccine
Introduction: For complete or functional cure of hepatitis B virus (HBV) infection ... can also elicit DC maturation and augment cross presentation of antigens in DCs, resulting in NK cell-mediated ...